Emergency Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia; National Trauma Research Institute, The Alfred Hospital, Melbourne, Australia.
Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia; National Trauma Research Institute, The Alfred Hospital, Melbourne, Australia; Emergency & Trauma Centre, The Alfred Hospital, Melbourne, Australia.
Eur Urol. 2018 Apr;73(4):583-595. doi: 10.1016/j.eururo.2017.11.001. Epub 2017 Nov 22.
Renal colic is a common, acute presentation of urolithiasis that requires immediate pain relief. European Association of Urology guidelines recommend nonsteroidal anti-inflammatory drugs (NSAIDs) as the preferred analgesia. However, the fear of NSAID adverse effects and the uncertainty about superior analgesic effect have maintained the practice of advocating intravenous opioids as the initial analgesia.
The objective of this systematic review and meta-analysis was to compare the safety and efficacy of NSAIDs with opioids and paracetamol (acetaminophen) for the management of acute renal colic.
Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, World Health Organization International Clinical Trials Registry Platform, Google Scholar, and the reference list of retrieved articles were searched up to December 2016 without language restrictions. Two reviewers independently assessed eligible studies using the Cochrane Collaboration tool for assessing and reporting the risk of bias and abstracted data using predefined data fields.
From 468 potentially relevant studies, 36 randomized controlled trials (RCTs) including 4887 patients, published between 1982 and 2016, were included in this systematic review. The treatment effect observed indicated marginal benefit of NSAIDs over opioids in initial pain reduction at 30min (11 RCTs, n=1985, mean difference [MD] -5.58, 95% confidence interval [CI] -10.22 to -0.95; heterogeneity I=81%). In the subgroup analyses by the route of administration, NSAIDs required fewer rescue treatments (seven RCTs, n=541, number needed to treat [NNT] 11, 95% CI 6-75) and had lower vomiting rates compared with opioids (five RCTs, n=531, NNT 5, 95% CI 4-8). Comparisons of NSAIDs with paracetamol showed no difference for both drugs at 30min (four RCTs, n=1325, MD -5.67, 95% CI -17.52 to 6.18, p=0.35; I=89%). Patients treated with NSAIDs required fewer rescue treatments (two trials, n=1145, risk ratio 0.56, 95% CI 0.42-0.74, p<0.001; I=0%).
NSAIDs were equivalent to opioids or paracetamol in the relief of acute renal colic pain at 30min. There was less vomiting and fewer requirements for rescue analgesia with NSAIDs compared with opioids. Patients treated with NSAIDs required less rescue analgesia compared with paracetamol. Despite observed heterogeneity among the included studies and the overall quality of evidence, the findings of a lower need for rescue analgesia and fewer adverse events, in conjunction with the practical advantages of ease of delivery, suggest that NSAIDs should be the preferred analgesic option for patients presenting to the emergency department with renal colic.
In kidney stone-related acute pain episodes in patients with adequate renal function, treatment with nonsteroidal anti-inflammatory drugs offers effective and most sustained pain relief, with fewer side effects, when compared with opioids or paracetamol.
肾绞痛是一种常见的急性尿路结石表现,需要立即缓解疼痛。欧洲泌尿外科学会指南推荐非甾体抗炎药(NSAIDs)作为首选的镇痛剂。然而,人们对 NSAID 不良反应的担忧以及对镇痛效果更好的不确定,使得静脉注射阿片类药物作为初始镇痛的做法得以维持。
本系统评价和荟萃分析旨在比较 NSAIDs 与阿片类药物和对乙酰氨基酚(扑热息痛)在治疗急性肾绞痛方面的安全性和疗效。
Cochrane 对照试验中心注册库、MEDLINE、EMBASE、世界卫生组织国际临床试验注册平台、Google Scholar 以及检索文章的参考文献列表均进行了检索,检索时间截至 2016 年 12 月,无语言限制。两名评审员使用 Cochrane 协作工具评估合格研究的偏倚风险,并使用预定义的数据字段提取数据。
从 468 项可能相关的研究中,纳入了 36 项随机对照试验(RCTs),共 4887 名患者,这些研究发表于 1982 年至 2016 年之间。治疗效果观察表明,NSAIDs 在 30 分钟时初始疼痛缓解方面略优于阿片类药物(11 项 RCTs,n=1985,平均差异[MD]-5.58,95%置信区间[CI]-10.22 至-0.95;异质性 I=81%)。通过给药途径的亚组分析,与阿片类药物相比,NSAIDs 需要较少的解救治疗(7 项 RCTs,n=541,需要治疗的人数[NNT]11,95%CI 6-75),且呕吐率较低(5 项 RCTs,n=531,NNT 5,95%CI 4-8)。NSAIDs 与对乙酰氨基酚的比较显示,在 30 分钟时两种药物均无差异(4 项 RCTs,n=1325,MD-5.67,95%CI-17.52 至 6.18,p=0.35;I=89%)。与阿片类药物相比,接受 NSAIDs 治疗的患者需要较少的解救治疗(2 项试验,n=1145,风险比 0.56,95%CI 0.42-0.74,p<0.001;I=0%)。
在缓解肾绞痛疼痛方面,NSAIDs 在 30 分钟时与阿片类药物或对乙酰氨基酚等效。与阿片类药物相比,NSAIDs 可减少呕吐和对解救性镇痛的需求。与对乙酰氨基酚相比,接受 NSAIDs 治疗的患者对解救性镇痛的需求更少。尽管纳入的研究存在异质性,证据总体质量也较低,但观察到需要较少的解救性镇痛和较少的不良反应,再加上给药的实际优势,提示在出现肾绞痛的患者中,NSAIDs 应作为首选的镇痛药物。
在肾功能正常的肾结石相关急性疼痛发作患者中,与阿片类药物或对乙酰氨基酚相比,非甾体抗炎药(NSAIDs)提供了更有效的、最持久的疼痛缓解,且副作用更少。